Calcium/cation-sensing receptor (CaSR) antagonist like NPS89636 for use in treating inflammatory lung disorders (asthma or COPD)

摘要

The invention concerns a calcium/cation-sensing receptor (CaSR) antagonist, in particular NPS89636, to treat an inflammatory lung disorder; a method of treatment involving said antagonist; a combination therapeutic comprising said antagonist and at least one other agent; and a nebuliser or inhaler containing same.